Glenmark Therapeutics Inc., USA, is a newly incorporated, wholly-owned subsidiary of Glenmark Holding, SA. The company is dedicated to building a franchise of branded products for Glenmark Pharmaceuticals, a global pharmaceutical company with operations in more than 50 countries. Glenmark Therapeutics will initially focus its efforts on launching and commercializing assets in the therapeutic areas of dermatology and respiratory. Glenmark Therapeutics has a short- and long-term pipeline of investigational medicines intended to meet the needs of patients suffering from a variety of dermatological and respiratory conditions and is consistently working to expand its product portfolio.
To receive medical or safety information or to report a product complaint or side effect (also called an adverse event), please contact the Glenmark customer service center at: GlobalCustomerService@glenmarkpharma.com or at 1-888-721-7115. Hours: 7:00 a.m. – 9:00 p.m., EST. The FDA has established a reporting service known as MedWatch, to which healthcare professionals and consumers can report serious problems they suspect may be associated with the drugs they prescribe, dispense or use. Visit MedWatch or call 1-800-FDA-1088. Additional information on how to report problems with medication, including a convenient, downloadable consumer guide, is available on the FDA website by clicking here.